Previous Page  1251 / 1816 Next Page
Information
Show Menu
Previous Page 1251 / 1816 Next Page
Page Background

Prognostic & predictive markers utilized in breast

cancer

ER/PR status

HER2 neu status

19-9-2017

Prognostic (recurrence risk)

Predictive (treatment benefit)

Axillary node status

Histologic type/grade/proliferation

index

Tumor size

Patient age

Performance status

Lymphatic/Vascular invasion

ER/PR status

HER2 neu status

Oncotype DX test

70 gene signature (mammaprint)